Condition
Huntington's Disease (HD)
Total Trials
3
Recruiting
0
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
P 2 (2)
Trial Status
Active Not Recruiting1
Completed1
Enrolling By Invitation1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07537075Phase 2Enrolling By InvitationPrimary
An Extension of SKY-0515 in Participants With Huntington's Disease
NCT07503743Active Not RecruitingPrimary
Biology-Driven Cognitive Profiling in Huntington's Disease
NCT01412151Phase 2CompletedPrimary
Creatine Safety & Tolerability in Huntington's Disease
Showing all 3 trials